In recent months, multiple cancer drugs have been in short supply in the United States. While the Food and Drug Administration and the American Society of Clinical Oncology have been working to resolve the shortages, patients with cancer are understandably concerned about getting the cancer treatment drugs they need and the amount required when the time comes.
Every year, nearly 80,000 new cases of melanoma are diagnosed, causing over 10,000 deaths annually. The incidence of melanoma is increasing by 2.6% every year and faster than almost every other malignancy.
Navigating breast cancer recovery can be lonely. To counter this, a nonprofit organization, Casting for Recovery, connects women who have breast cancer or a history of breast cancer through healing fly-fishing retreats.
Mohs surgery is an effective way to treat skin cancer. By pinpointing the cancer and removing it with precision, Mohs surgery gives high cure rates and allows for tissue conservation.
Pancreatic cancer is considered rare, with an estimated 62,210 new cases diagnosed in the U.S. in 2022. Even so, it is the third-leading cause of cancer-related death in the U.S.
University of Nebraska Medical Center researchers are studying an experimental treatment for patients with specific subtypes of B-cell non-Hodgkin lymphomas. Potential candidates include patients who have undergone prior standard therapies that are no longer working or who have had cancer continue to return.
Cancer is a complex topic that includes more than 100 diseases. Research studies continue looking for answers to discover what may contribute to or cause cancer to develop in the first place.
Multiple myeloma is a bone marrow cancer in which plasma cells have become cancerous. Plasma cells, a type of white blood cell, are an essential part of the immune system. They make antibodies, a type of protein, that help fight infections.
